Guggenheim Securities acted as lead bookrunner for the offering. Oppenheimer & Co. and LifeSci Capital also acted as bookrunners for the offering. Raymond James and Needham & Company acted as co-lead ...
Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...
Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsDouglas Love - CEO, President ...
Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and ...
Terry Flotte, MD, steps down as ASGCT president at the end of this week. In this exclusive interview, Terry shares the ...
Biologists have long puzzled over why organisms with similar numbers of protein-coding genes can differ so dramatically in ...
From tumour growth to treatment response, experts believe gut bacteria may play a far bigger role in liver cancer than ...
President John Dramani Mahama has announced that the government will no longer grant blanket tax exemptions for imported ...
InflaRx ( (IFRX)) has provided an announcement. On May 4, 2026, InflaRx reported new preclinical data showing that its investigational C5aR1 inhibitor izicopan generates minimal reactive metabolites ...
However, quince has a lot to offer in terms of health benefits. Rich in vitamins and minerals, this fruit can contribute to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results